US Patent Issued to SERPIN PHARMA on May 6 for "Serpin peptides and methods of using the same" (Virginia, Colorado Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,581, issued on May 6, was assigned to SERPIN PHARMA LLC (Manassas, Va.).

"Serpin peptides and methods of using the same" was invented by Soren Mogelsvang (Boulder, Colo.) and Cohava Gelber (Manassas, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "We describe peptides and their uses for the treatment of autoimmune, inflammatory and metabolic diseases."

The patent was filed on Dec. 16, 2020, under Application No. 17/124,301.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=1229158...